PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, supplying promising advancements throughout several health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, more trusted choice for therapeutic use, especial